Digital Biomarker for PH
Pulmonary Hypertension
Early DevelopmentActive
Key Facts
About electronRx
Digital‑biomarker platform that delivers continuous, AI‑powered insights for respiratory disease drug development.
View full company profileTherapeutic Areas
Other Pulmonary Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| CAR Liposomes | Vascular Biosciences | Pre-clinical |
| Telaglenastat (Inhaled) | Synhale Therapeutics | Preclinical |